137 related articles for article (PubMed ID: 3165292)
1. Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics.
San Miguel JF; Gonzalez M; Cañizo MC; Ojeda E; Orfao A; Caballero MD; Moro MJ; Fisac P; Lopez Borrasca A
Blood; 1988 Aug; 72(2):402-7. PubMed ID: 3165292
[TBL] [Abstract][Full Text] [Related]
2. Cell surface phenotyping of megakaryoblasts.
Koike T; Aoki S; Maruyama S; Narita M; Ishizuka T; Imanaka H; Adachi T; Maeda H; Shibata A
Blood; 1987 Mar; 69(3):957-60. PubMed ID: 3028539
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of peroxidase negative acute leukemias by monoclonal antibodies--II. Acute megakaryoblastic and acute pro-megakaryocytic leukemias.
Imamura N; Kajihara H; Kuramoto A
Leuk Res; 1988; 12(4):279-89. PubMed ID: 3163741
[TBL] [Abstract][Full Text] [Related]
4. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
5. Target cell of leukemic transformation in acute megakaryoblastic leukemia.
Koike T; Urushiyama M; Narita M; Saitoh H; Ishida F; Imashuku S; Morioka Y; Utsumi J; Ishizuka T; Tsuruta T
Am J Hematol; 1990 Aug; 34(4):252-8. PubMed ID: 2164321
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
Zipursky A; Christensen H; De Harven E
Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
[TBL] [Abstract][Full Text] [Related]
7. Refractory anemia terminating in acute megakaryoblastic leukemia (M7).
Adachi M; Ryo R; Yoshida A; Yamaguchi N; Izumi Y
Acta Haematol; 1989; 81(2):104-8. PubMed ID: 2496548
[TBL] [Abstract][Full Text] [Related]
8. Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients.
Cuneo A; Mecucci C; Kerim S; Vandenberghe E; Dal Cin P; Van Orshoven A; Rodhain J; Bosly A; Michaux JL; Martiat P
Blood; 1989 Oct; 74(5):1781-90. PubMed ID: 2790202
[TBL] [Abstract][Full Text] [Related]
9. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
Kojima S; Matsuyama T; Sato T; Horibe K; Konishi S; Tsuchida M; Hayashi Y; Kigasawa H; Akiyama Y; Okamura J
Blood; 1990 Dec; 76(11):2348-53. PubMed ID: 2147864
[TBL] [Abstract][Full Text] [Related]
10. Expression of the thrombospondin receptor (CD36) on the cell surface in megakaryoblastic and promegakaryocytic leukemias: increment of the receptor by megakaryocyte differentiation in vitro.
Imamura N; Ota H; Abe K; Kuramoto A
Am J Hematol; 1994 Feb; 45(2):181-4. PubMed ID: 7511332
[TBL] [Abstract][Full Text] [Related]
11. High Ia (HLA-DR) and low CD11b (Mo1) expression may predict early conversion to leukemia in myelodysplastic syndromes.
Mittelman M; Karcher DS; Kammerman LA; Lessin LS
Am J Hematol; 1993 Jul; 43(3):165-71. PubMed ID: 8352230
[TBL] [Abstract][Full Text] [Related]
12. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo.
Takeuchi S; Sugito S; Uemura Y; Miyagi T; Kubonishi I; Taguchi H; Enzan H; Ohtsuki Y; Miyoshi I
Leukemia; 1992 Jun; 6(6):588-94. PubMed ID: 1602796
[TBL] [Abstract][Full Text] [Related]
13. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Holt SE; Brown EJ; Zipursky A
J Pediatr Hematol Oncol; 2002 Jan; 24(1):14-7. PubMed ID: 11902731
[TBL] [Abstract][Full Text] [Related]
14. Morphologic and flow cytometric analysis of circulating megakaryoblasts in chronic myeloid leukaemia.
Matolcsy A; Kálmán E; Pajor L; Kónya T; Weber E
Leuk Res; 1991; 15(10):887-97. PubMed ID: 1921449
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis.
Tange T; Nakahara K; Mitani K; Yamasaki I; Yasuda H; Tanaka F; Mizuguchi M; Oda H; Yatomi Y; Takanashi R
Cancer Res; 1988 Nov; 48(21):6137-44. PubMed ID: 3167860
[TBL] [Abstract][Full Text] [Related]
16. Frequency and distribution of megakaryoblasts in FAB subtypes of ANLL: an immunocytochemical ultrastructural study.
Tomasi P; Tallarico A; Vasi V; Scapoli G; Castoldi G
Haematologica; 1993; 78(2):95-100. PubMed ID: 7688710
[TBL] [Abstract][Full Text] [Related]
17. Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome.
Yumura-Yagi K; Hara J; Kurahashi H; Nishiura T; Kaneyama Y; Osugi Y; Sakata N; Inoue M; Tawa A; Okada S
Br J Haematol; 1992 Aug; 81(4):520-5. PubMed ID: 1390239
[TBL] [Abstract][Full Text] [Related]
18. Childhood acute megakaryoblastic leukemia with internalization of hemic cells.
Shimizu H; Ui T; Sasaki K; Kawai S; Kaneko Y; Fujimoto T
Am J Pediatr Hematol Oncol; 1990; 12(4):477-9. PubMed ID: 2285130
[TBL] [Abstract][Full Text] [Related]
19. Limits of phenotypic markers for the diagnosis of megakaryoblastic leukemia.
Breton-Gorius J; Villeval JL; Kieffer N; Mitjavila MT; Guichard J; Vainchenker W
Blood Cells; 1989; 15(1):259-77. PubMed ID: 2649184
[TBL] [Abstract][Full Text] [Related]
20. Biology, clinical, and hematologic features of acute megakaryoblastic leukemia in children.
Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Trejo RA
Am J Hematol; 2003 Jun; 73(2):71-80. PubMed ID: 12749007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
